With the increasing use of genome sequencing as a surveillance tool for molecular epidemiology of antimicrobial resistance, we are seeing an increased intersection of genomics, microbiology, and clinical epidemiology. Clear nomenclature for AMR gene families and pathogens is critical for communication. For CARD release version 3.0.3 (July 2019), we updated the entire CARD database to reflect the latest pathogen names. In total, we detected 48 name changes or updates, some of which reflect major changes in familiar names.
Introduction
With the increasing use of genome sequencing as a surveillance tool for molecular epidemiology of antimicrobial resistance (AMR) (1, 2), we are seeing an increased intersection of genomics, microbiology, and clinical epidemiology. As such, clear nomenclature for AMR gene families and pathogens is critical for communication. At the Comprehensive Antibiotic Resistance Database (CARD) (3), we provide highly curated reference data on the molecular basis of AMR. As a rule, sequences added to CARD must include peer-reviewed, published experimental evidence of antibiotic minimum inhibitory concentration (MIC) elevated above that of a control, plus availability of the DNA sequence of the corresponding gene or mutant in GenBank (4) . All data is organized ontologically, most notably using the Antibiotic Resistance Ontology and an ontological mirror of GenBank's Taxonomy Database (3). Yet, since its inception CARD has not performed an update of the microbiological taxonomy and nomenclature underlying its organization of AMR sequences, predicted allelic variants, resistome annotations, and epidemiological estimates. As such, for CARD release version 3.0.3 (July 2019) we added a new software module to our CARD Quality Control tools to detect nomenclatural changes in GenBank not incorporated into CARD, which we then used to update the CARD database to reflect the latest pathogen names. In total, we detected 48 name changes or updates, some of which reflect major changes in familiar names (Table 1 ). These changes are outlined below with citations for convenience and clarity, using the acronym p.k.a. for "previously known as". 
Cutibacterium acnes (p.k.a. Propionibacterium acnes)
Propionibacterium acnes is a Gram-positive bacterium involved in the pathogenesis of acne. Originally known Bacillus acnes, the species was renamed Cutibacterium acnes by Scholz & Kilian (7) based on genome and phylogenetic analysis. In CARD, Cutibacterium acnes has been associated with gyrA and 16S rRNA mutations conferring resistance to fluoroquinolones and tetracycline, respectively.
Kitasatospora aureofaciens (p.k.a. Streptomyces aureofaciens)
Streptomyces aureofaciens is widely known as a source of many tetracycline antibiotics (8) and in many ways represents the archetype for antibiotic producing Streptomyces. However, multi-gene phylogenetic analyses (9) have illustrated that this species is a member of the genus Kitasatospora, hence a name change to Kitasatospora aureofaciens has been adopted.
Borreliella burgdorferi (p.k.a. Borrelia burgdorferi)
The spirochete bacteria Borrelia burgdorferi is a tick-borne causative agent of Lyme disease and thus a focus of considerable scrutiny for vaccine and drug development, as well as molecular epidemiology (10) . Yet, phylogenomic investigation has split the genus into Borrelia and Borreliella (11) , resulting in the new and validated name Borreliella burgdorferi.
Klebsiella aerogenes (p.k.a. Enterobacter aerogenes)
The familiar ESKAPE pathogen Enterobacter aerogenes has a long nomenclatural history. This Gram-negative, opportunistic pathogen was originally included as Aerobacter aerogenes and later renamed Enterobacter aerogenes based on nomenclatural rules, but as early as 1971 it was realized that not all strains of Enterobacter were likely to be of the same genus and that Enterobacter aerogenes was more likely a member of Klebsiella (12, 13) . Nomenclatural rules at the time blocked this name change, but recognition of overlapping types (NCTC 10006, ATCC 13048) resulted in the short-lived moniker Klebsiella mobilis (i.e. Klebsiella mobilis and Enterobacter aerogenes are homotypic synonyms). Tindall et al. (13) reviewed this naming history and current nomenclatural rules, resulting in the definitive and widely adopted change to Klebsiella aerogenes. It is worth noting that this taxonomic revision complicates the familiar ESKAPE pathogens acronym for prevalent, AMR hospital acquired infections: Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species ("Klebsiella pneumoniae" could be replaced with "Klebsiella species"). From a phenotypic point of view, care should be taken for assumptions of antimicrobial susceptibilities, since Klebsiella aerogenes has a different AMR gene compliment than other Klebsiella. 
Mycobacterium, Mycobacteroides, & Mycolicibacterium

Conclusions
A large number of databases relating to AMR exist (see CARD's amr_curation repo and Google spreadsheet list of databases at https://github.com/arpcard/amr_curation), yet most curate a molecular sequence once, reflecting its initial report, as is done at CARD. This initial report and entry in GenBank often reflect a gene's original detection in a single pathogen, yet AMR is an evolutionary process involving both evolution of the AMR sequences themselves over time and their horizontal gene transfer among pathogens. As such, AMR databases must do more than form a collection of reference sequences, but over time must track their evolution and epidemiological distribution. To do this well, AMR databases must update molecular sequences as well as our understanding of pathogen relationships. As AMR is an evolutionary phenomena, our analyses of AMR must also have an accurate evolutionary context which is most often reflected in the names of microbes. As illustrated above, bacterial nomenclature is increasingly guided by comparative genomic, phylogenetic, and phylogenomic analyses. Ignoring these nomenclatural changes places our analyses and interpretation of AMR into incorrect context. AMR databases need to update microbial nomenclature to remain relevant. Yet, in clinical settings nomenclatural changes in academia often can appear arbitrary, as familiar monikers are important for clinical diagnostics, public health decisions, and clear lines of communication. As outlined in Dr. Audrey Schuetz's online article (15) , changes in nomenclature can disrupt clinical processes and have unanticipated costs. As such, and following GenBank's lead, CARD now strives to follow the latest changes in bacterial nomenclature and as it is based on both the Chado data schema and organized exclusively using ontologies (3), is able to rapidly update names and descriptions within CARD to reflect the latest nomenclature while simultaneously supporting depreciated names as ontological synonyms, allowing users to search CARD using familiar monikers in case they are unfamiliar with recent name changes, allowing them to find the data they need.
